NIH Halts 2 Studies Of Hydroxychloroquine, Saying Drug Likely Ineffective As Treatment For Novel Coronavirus

New York Times: Federal Agency Halts Studies of Hydroxychloroquine, Drug Trump Promoted
“The National Institutes of Health said Saturday that it had stopped two clinical trials of hydroxychloroquine, the malaria drug that President Trump promoted to treat and prevent the coronavirus, one because the drug was unlikely to be effective and the other because not enough patients signed up to participate…” (Thomas, 6/20).

Additional coverage NIH’s cessation of hydroxychloroquine clinical trials is available from CNBC, CNN, The Hill, NPR, and POLITICO.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.